These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7366802)

  • 1. An inability of subcutaneous vasopressin to affect passive avoidance behavior.
    Hostetter G; Jubb SL; Kozlowski GP
    Neuroendocrinology; 1980; 30(3):174-7. PubMed ID: 7366802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.
    Boccia MM; Kopf SR; Baratti CM
    Neurobiol Learn Mem; 1998 Mar; 69(2):136-46. PubMed ID: 9619993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin analogs: sedative properties and passive avoidance behavior in rats.
    Krejcí I; Kupková B; Metys J; Barth T; Jost K
    Eur J Pharmacol; 1979 Jul; 56(4):347-53. PubMed ID: 477729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive avoidance behavior, vasopressin and the immune system. A link between avoidance latency and immune response.
    Croiset G; Heijnen CJ; de Wied D
    Neuroendocrinology; 1990 Feb; 51(2):156-61. PubMed ID: 2106096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential localization of the influence of lysine vasopressin and of ACTH 4-10 on avoidance behavior: a study in rats bearing lesions in the parafascicular nuclei.
    v Wimerdma Greidanus TB; Bohus B; de Wied D
    Neuroendocrinology; 1974; 14(5):280-8. PubMed ID: 4368018
    [No Abstract]   [Full Text] [Related]  

  • 6. Choice, as opposed to latency, measures in avoidance suggest that vasopressin and oxytocin do not affect memory in rats.
    Sahgal A; Wright C
    Neurosci Lett; 1984 Aug; 48(3):299-304. PubMed ID: 6483287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral vasopressin accelerates extinction of conditioned taste avoidance.
    Hayes UL; Chambers KC
    Physiol Behav; 2005 Jan; 84(1):147-56. PubMed ID: 15642618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pinealectomy and melatonin on vasopressin-potentiated passive avoidance in rats.
    Juszczak M; Drobnik J; Guzek JW; Schwarzberg H
    J Physiol Pharmacol; 1996 Dec; 47(4):621-7. PubMed ID: 9116329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin.
    Kovács GL; Liu B; Burbach JP; Van Ree JM; De Wied D
    Eur J Pharmacol; 1989 Feb; 161(1):27-35. PubMed ID: 2721547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vasopressin on active and passive avoidance behavior.
    Bohus B; Ader R; de Wied D
    Horm Behav; 1972 Sep; 3(3):191-7. PubMed ID: 4680509
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral injections of vasopressin control behavior by way of interoceptive signals for hypertension.
    Bluthé RM; Dantzer R; Le Moal M
    Behav Brain Res; 1985; 18(1):31-9. PubMed ID: 4091954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebroventricular but not intraperitoneal administration of aluminum attenuates vasopressin-enhanced retrieval of a passive avoidance task in rats.
    Bernstein HG; Schwarzberg H; Poeggel G; Reiser M
    Pharmacol Biochem Behav; 1994 Mar; 47(3):587-90. PubMed ID: 8208778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment?
    Ebenezer IS
    Neuropharmacology; 1988 Sep; 27(9):903-7. PubMed ID: 3185866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mammillary body, a potential site of action of neurotensin in passive avoidance behavior in rats.
    Shibata K; Furukawa T
    Brain Res; 1988 Mar; 443(1-2):117-24. PubMed ID: 3129133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel changes in behaviour and hippocampal serotonin metabolism in rats following treatment with desglycinamide lysine vasopressin.
    Ramaekers F; Rigter H; Leonard BE
    Brain Res; 1977 Jan; 120(3):485-92. PubMed ID: 556678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory effects of arginine vasopressin (AVP) and [7-9] fragment of its peptide chain in rats.
    Klimkiewicz T
    Acta Neurobiol Exp (Wars); 2001; 61(4):267-76. PubMed ID: 11905148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microinjection of anti-vasopressin serum into limbic structures of the rat brain: effects on passive avoidance responding and on local catecholamine utilization.
    Veldhuis HD; van Wimersma Greidanus TB; Versteeg DH
    Brain Res; 1987 Nov; 425(1):167-73. PubMed ID: 3427417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of lysine-vasopressin upon short-term recall of a noxious significance.
    Frucht-Celaru M; Sterescu-Volanschi M
    Physiologie; 1975; 12(4):285-9. PubMed ID: 814562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal administration of two peptide solutions affects passive avoidance behaviour of young rats.
    Paier B; Windisch M; Eggenreich U
    Behav Brain Res; 1992 Oct; 51(1):23-8. PubMed ID: 1336389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of arginine-vasopressin in cerebrospinal fluid during passive avoidance behavior in rats.
    Laczi F; Gaffori O; Fekete M; de Kloet ER; de Wied D
    Life Sci; 1984 Jun; 34(24):2385-91. PubMed ID: 6727572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.